The FDA has even authorised a drug made with cannabidiol for that objective (Epidiolex). But the agency only recommends it for 2 rare varieties of childhood epilepsy known as Lennox-Gastaut syndrome and Dravet syndrome.In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify marijuana to be a Routine III drug. … Read More